Safety
GHRP-2
Adverse-event report summary for GHRP-2, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 4
- Reports flagged serious
- 3
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Urticaria2 reports
- Abdominal Pain Upper1 reports
- Burning Sensation1 reports
- Injection Site Urticaria1 reports
- Nausea1 reports
- Pain1 reports
- Pancreatitis Acute1 reports
- Product Lot Number Issue1 reports
- Product Physical Consistency Issue1 reports
- Product Quality Issue1 reports
- Pruritus1 reports
- Pyrexia1 reports
- Rash Pustular1 reports
- Vomiting1 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.